Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fattystreaks, intermediate lesions and advanced atherosclerotic lesions
Sl. Hazen et al., Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fattystreaks, intermediate lesions and advanced atherosclerotic lesions, BIOCHEM J, 352, 2000, pp. 693-699
Reactive aldehydes might have a pivotal role in the pathogenesis of atheros
clerosis by covalently modifying low-density lipoprotein (LDL). However, th
e identities of the aldehyde adducts that form on LDL in vivo are not yet c
learly established. We previously demonstrated that the haem protein myelop
eroxidase oxidizes proteins in the human artery wall, We also have shown th
at p-hydroxyphenylacetaldehyde (pHA), the aldehyde that forms when myeloper
oxidase oxidizes L-tyrosine, covalently modifies the N-epsilon-lysine resid
ues of proteins. The resulting Schiff base can be quantified as N-epsilon-[
2-(p-hydroxyphenyl)ethyl]lysine (pHA-lysine) after reduction with NaCNBH3.
Here we demonstrate that pHA-lysine is a marker for LDL that has been modif
ied by myeloperoxidase, and that water-soluble, but not lipid-soluble, anti
oxidants inhibit the modification of LDL protein. To determine whether myel
operoxidase-generated aldehydes might modify LDL in vivo, we used a combina
tion of isotope-dilution GC-MS to quantify pHA-lysine in aortic tissues at
various stages of lesion evolution, We also analysed LDL isolated from athe
rosclerotic aortic tissue, Comparison of normal and atherosclerotic aortic
tissue demonstrated a significant elevation (more than 10-fold) of the redu
ced Schiff base adduct in fatty streaks, intermediate lesions and advanced
lesions compared with normal aortic tissue. Moreover, the level of pHA-lysi
ne in LDL recovered from atherosclerotic aortic intima was 200-fold that in
plasma LDL of healthy donors. These results indicate that pHA-lysine, a sp
ecific covalent modification of LDL, is generated in human atherosclerotic
vascular tissue. They also raise the possibility that reactive aldehydes ge
nerated by myeloperoxidase have a role in converting LDL into an atherogeni
c lipoprotein.